Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR® Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) a clinical-stage biopharmaceutical company developing CD19…
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials…
Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing Students Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky’s…
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ:…
China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro…
Cleveland Diagnostics Appoints Michael Iskra as CEO to Accelerate Growth Following FDA Approval of IsoPSA® Assay Cleveland Diagnostics, a pioneering commercial-stage precision oncology company, has announced the appointment of Michael…
Dental Intelligence Appoints Scott Johnson as CEO to Lead Next Phase of Growth and Innovation Dental Intelligence, a leading provider of practice performance solutions for the dental industry, today announced…
ACES Expands Arizona Footprint With Acquisition of Ally Pediatric Therapy, Strengthening Access to High-Quality ABA Services Across Greater Phoenix ACES, a leading clinically driven provider of autism therapy services in…
Travere Therapeutics Reports Record FILSPARI Performance in 4Q 2025, Advances Regulatory and Clinical Milestones Ahead of 2026 Travere Therapeutics a biopharmaceutical company focused on developing and delivering transformative therapies for…
Compass Pathways partners with Radial Health to inform scalable COMP360 psilocybin delivery models and patient experience innovation across U.S. psychiatry clinics. Compass Pathways Radial collaboration marks a calculated step in…
ResearchAndMarkets.com has announced the addition of a new report titled “Europe Image-Guided Drug Delivery Market: Focus on Technology Type, Application, End User, and Country Analysis (2025–2035).” The report provides a…
Introductory EU Veterinary Drug Safety Course (Mar 2026) The “Introduction to Veterinary Pharmacovigilance Training Course (March 9–10, 2026)” has been added to the growing portfolio of professional training programs available…